TrialOncotarget2017

Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.

Nilofer S Azad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.